PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

Ann: 2021 Annual Report and Appendix 4E, page-82

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,384 Posts.
    lightbulb Created with Sketch. 6929
    In truth WRpar20, there is a lot more to answer you properly and it would warrant some more study. Its far more complex than just a few line here, for example it depends on how the drug binds, what it binds to, absorption rates, the stability of the drug (in our case for example, thankfully, ours is stable at room temperature thus lends itself better to a SubQ route of admin.).

    There are many factors, even maths gets involved here with Log Values...yeh I'd have to read up on that stuff cos it is been more than 30 years since I had to deal with logs...err the maths ones, not the wood ones...

    The other advantage of SubQ for us is that it is easier to self-administer and this becomes more important when it is more than just one or two injections as part of the first course for example.

    - Mozz

    Last edited by Mozzarc: 03/09/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.5¢
Change
0.000(0.00%)
Mkt cap ! $92.81M
Open High Low Value Volume
27.0¢ 29.0¢ 25.5¢ $430.3K 1.585M

Buyers (Bids)

No. Vol. Price($)
1 5500 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 36162 3
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.